Neurological disorders are the leading cause of disability and the second-leading cause of death worldwide, but UArizona researchers have developed a new class of drugs that is able to cross the blood-brain barrier for treatments.

Tech Launch Arizona commercializes inventions stemming from research, hosted its ninth annual I-Squared Awards and Expo event. Along with honoring the top inventors, entrepreneurs, and community leaders dedicated to commercializing UArizona inventions.

For the first time, UArizona innovators have reported more than 300 world-improving inventions in a single year.

UArizona has licensed the new class of drugs designed to penetrate the blood-brain barrier that could be used to treat degenerative neurological diseases and conditions to startup Teleport Pharmaceuticals and inventor Dr. Robin Polt.

UArizona Engineering professors are recognized for achievements in fiber optic switching and high-tech optical sensors.

The National Academy of Inventors has named the Senior Members of the 2022 class including BIO5's Drs. Steven Goldman, Robin Polt, and Judith Su.

Tech Launch Arizona has kicked off a new UArizona program to recognize inventors who are named on issued patents

More than 1.5B people live with chronic pain worldwide, the most common cause of long-term disability in the US, and several BIO5 researchers are addressing the issue tackling the opioid epidemic using basic science and clinical approaches.

BIO5 Institute member Meredith Hay started ProNeurogen Inc., a company based on inventions rising out of research in neuroscience and cardiovascular neurophysiology.